Skip to search formSkip to main contentSkip to account menu

N 0923

Known as: N-0923 
National Institutes of Health

Related topics

Related topics

1 relation
Rotigotine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Novel pharmaceutical compositions for the administration of N-0923
The present invention relates to pharmaceutical compositions for the administration of the N-0923 is a dopamine agonist in depot… 
2001
2001
Novel pharmaceutical compositions for the administration of N-0923
The invention relates to a pharmaceutical composition for administering the dopamine agonist N-0923 in depot form. The invention… 
1995
1995
Improved bioavailability of the D2-dopamine agonist N-0923 after buccal, nasal or rectal administration compared with oral dosing
The absorption characteristics after buccal, nasal and rectal administration of N-0923 (S-(—)-2-(N-propyl-N-2-thienylethylamino… 
1994
1994
Determination of the dopamine D2 agonist N-0923 and its major metabolites in perfused rat livers by HPLC-UV-atmospheric pressure ionization mass spectrometry.
The metabolism of the dopamine D2 agonist N-0923 was investigated by an in vitro isolated liver perfusion. Determining the… 
1992
1992
Bioanalysis and pharmacokinetics of the dopamine D2 agonist N-0923
This thesis describes the bioanalysis and pharmacokinetics of the S(-) enantiomer (N-0923) of the selective and potent dopamine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)